The goals of this proposal are to investigate the basic cellular mechanisms that underlie the complex functions of the brain microcirculation, and how this circulation is controlled to meet the fastidious requirements of the brain. The endothelial cells of brain microvessels stand at the interface between the systemic circulation and nervous tissue, and have a vital role in maintaining a stable environment for neuronal function. To accomplish this, the brain capillary endothelium is endowed with unique features, such as tight intercellular junctions, and a variety of transporters for essential lipid-insoluble molecules like glucose and amino acids. Many gaps remain in our knowledge of the basic cellular mechanisms underlying the complex functions of the brain's blood vessels. The proposed experiments will employ complementary biochemical, pharmacological, and ultrastructural techniques to study the brain microcirculation in intact tissue, and in preparations enriched with isolated microvessels. The experiments will address: (1) Cellular mechanisms by which adenosine and its analogues exert their affects on the cerebral circulation. Adenosine receptors and the adenosine transporter will be investigated in isolated cerebral microvessels by ligand binding techniques. (2) The presence of receptors for putative peptide neurotransmitters which may regulate the cerebral circulation: angiotensin II, vasopressin, cholecystokin, and vasoactive intestinal polypeptide. (3) Ultrastructural investigation of heterogeneities in the distribution of the glucose transporter and sodium, potassium-ATPase in different brain regions, and within the microvascular unit, by immunocytochemical methods. (4) Isolation and biochemical characterization of the basal lamina of brain microvessels. (5) Biochemical determination and possible ultrastructural localization of carbonic anhydrase in cerebral microvessels. A better understanding of how the brain microcirculation functions may be a prerequisite for appreciating the pathophysiology of the cerebral circulation. This research may provide scientific bases for rational therapy of cerebral vascular disorders, metabolic encephalopathies and blood-brain barrier dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL035617-02
Application #
3349637
Study Section
(SRC)
Project Start
1985-09-30
Project End
1988-09-29
Budget Start
1986-09-30
Budget End
1987-09-29
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Harik, N; Harik, S I; Kuo, N T et al. (1996) Time-course and reversibility of the hypoxia-induced alterations in cerebral vascularity and cerebral capillary glucose transporter density. Brain Res 737:335-8
Al-Mudallal, A S; LaManna, J C; Lust, W D et al. (1996) Diet-induced ketosis does not cause cerebral acidosis. Epilepsia 37:258-61
LaManna, J C; Kutina-Nelson, K L; Hritz, M A et al. (1996) Decreased rat brain cytochrome oxidase activity after prolonged hypoxia. Brain Res 720:1-6
Harik, S I; Lust, W D; Jones, S C et al. (1995) Brain glucose metabolism in hypobaric hypoxia. J Appl Physiol 79:136-40
Harik, S I; Hritz, M A; LaManna, J C (1995) Hypoxia-induced brain angiogenesis in the adult rat. J Physiol 485 ( Pt 2):525-30
al-Mudallal, A S; Levin, B E; Lust, W D et al. (1995) Effects of unbalanced diets on cerebral glucose metabolism in the adult rat. Neurology 45:2261-5
Harik, S I; Behmand, R A; LaManna, J C (1994) Hypoxia increases glucose transport at blood-brain barrier in rats. J Appl Physiol 77:896-901
Mironov, V; Hritz, M A; LaManna, J C et al. (1994) Architectural alterations in rat cerebral microvessels after hypobaric hypoxia. Brain Res 660:73-80
Holash, J A; Harik, S I; Perry, G et al. (1993) Barrier properties of testis microvessels. Proc Natl Acad Sci U S A 90:11069-73
Harik, S I; Riachi, N J; Hritz, M A et al. (1993) Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies. J Pharmacol Exp Ther 266:790-5

Showing the most recent 10 out of 54 publications